This alteration could reduce the transcriptional activity and regulate the lipoprotein lipase activity, thereby affecting the removal of triglycerides, which leads to atherosclerosis due to dyslipidemia (Schneider et al., 2002). Here, LPL is linked to metabolic syndrome.